Maya Abdallah: SIOG 2026 Brings New Focus to Geriatric Assessment in AML
Maya Abdallah and Sam Yates/LinkedIn

Maya Abdallah: SIOG 2026 Brings New Focus to Geriatric Assessment in AML

Maya Abdallah, Assistant Professor at Boston University School of Medicine, shared a post on LinkedIn by Sam Yates, Assistant Professor at Wake Forest University School of Medicine, adding:

“Interested in geriatric assessment in AML? Join us at SIOG 2026!

Thanks, Sam Yates, for putting together a wonderful program!

Excited to co-chair this session with you and looking forward to a great discussion!”

Quoting Sam Yates:

“If you will be at SIOG next month please join us for the Hematology Session discussing the role of the geriatric assessment in the current treatment landscape for older adults with AML!

Thrilled to co-chair this session with Maya Abdallah this year!”

Sam Yates also shared SIOG – International Society of Geriatric Oncology‘s post on LinkedIn:

“Lower-intensity therapies have largely replaced intensive regimens for older adults with AML, and recent results from the PARADIGM trial have pushed the question further:

Should any older adult receive intensive induction?

The Haematology Interest Group session at SIOG 2026 looks at what geriatric assessment adds to that decision now.

Maya Abdallah: SIOG 2026 Brings New Focus to Geriatric Assessment in AML

Gabriela Rodríguez Macías, Samuel Yates and Mariam Nawas cover intensive induction, GA-guided supportive care for sarcopenia, and transplant candidacy.

Steve Hodges and Patricia Brennan-Hodges close the session with what matters most when patients and clinicians decide together.

If you treat older adults with haematological cancers, join us for the discussion.

Registration fees are €50 lower until Sunday 18 October.

Register now.”

You may also be interested in: SIOG 2026 Showcases 280 Geriatric Oncology Posters and Offers Lower Registration Fees Until October 18 

Maya Abdallah: SIOG 2026 Brings New Focus to Geriatric Assessment in AML